Your shopping cart is empty

Subscriber login

REGISTER FOR FREE EZINES

Advanced Search

Home
Books
Conferences
DVDs
Newsletters
Form 483s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us

E-Zines

Check out our free and informative ezines and sign up now

Home > Newsletters > Drug Industry Daily > Hospira Has Second Opioid Lot Recall in a Month on Overfills

Drug Industry Daily

May 15, 2012 | Vol. 11 No. 96

Hospira Has Second Opioid Lot Recall in a Month on Overfills

Hospira is recalling one lot of hydromorphone hydrochloride injection after two reports of overfills in the syringe-based drug delivery system.

This article is viewable by subscribers only. To view this article, please select an option below.

Subscribe
Print This Page
Email This Article
RSS
Free Trial
Archives
Sample PDF

Related Articles

FDA Enforcement Actions Target Foreign Particles in Drugs Ranbaxy Compliance Reforms Reflect FDA Manufacturing Recommendations Fatality Sparks Swiss Recall of AMAG’s Anemia Drug Australia Revises GMPs for Human Blood, Tissue Products

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.

ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews

All rights reserved. Do not duplicate or redistribute in any form.